Publications
33
Citations
692
Est. group size
—
Recurring co-author estimate
Active years
10
Publishing since 2017
Typically publishes in teams of ~9 · 3% small-team papers (≤3 authors) · across 17 venues
- Tu1529 A DEFINED BACTERIAL CONSORTIUM, VE202, COLONIZED PATIENTS WITH ULCERATIVE COLITIS (UC): RESULTS OF A PHASE 2 STUDY
Gastroenterology · 2026
- Tu1540 CHANGES IN FECAL CALPROTECTIN AND ENTEROBACTERIACEAE ABUNDANCE IN RESPONSE TO A DEFINED BACTERIAL CONSORTIUM, VE202, IN PATIENTS WITH ULCERATIVE COLITIS (UC)
Gastroenterology · 2026
- Tu1534 EFFICACY AND SAFETY OF A DEFINED BACTERIAL CONSORTIUM, VE202, IN ADULTS WITH MILD TO MODERATE ULCERATIVE COLITIS (UC): WEEK 8 RESULTS FROM THE PHASE 2 COLLECTIVE202 STUDY
Gastroenterology · 2026
- Tu1529 A DEFINED BACTERIAL CONSORTIUM, VE202, COLONIZED PATIENTS WITH ULCERATIVE COLITIS (UC): RESULTS OF A PHASE 2 STUDY
Gastrointestinal Endoscopy · 2026
- Tu1540 CHANGES IN FECAL CALPROTECTIN AND ENTEROBACTERIACEAE ABUNDANCE IN RESPONSE TO A DEFINED BACTERIAL CONSORTIUM, VE202, IN PATIENTS WITH ULCERATIVE COLITIS (UC)
Gastrointestinal Endoscopy · 2026
- Tu1534 EFFICACY AND SAFETY OF A DEFINED BACTERIAL CONSORTIUM, VE202, IN ADULTS WITH MILD TO MODERATE ULCERATIVE COLITIS (UC): WEEK 8 RESULTS FROM THE PHASE 2 COLLECTIVE202 STUDY
Gastrointestinal Endoscopy · 2026
- Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection
Nature Medicine · 2025
- Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial
Gut Microbes · 2025
- Safety and efficacy of a defined bacterial consortium, VE303, to treat HE
Hepatology Communications · 2025
- Author Correction: Gut microbiota strain richness is species specific and affects engraftment
Nature · 2025
- 377. Impact of VE303, a Defined Bacterial Consortium, on Antimicrobial Resistant Gene Prevalence in Patients with <i>Clostridioides difficile</i> Infection (CDI)
Open Forum Infectious Diseases · 2025
- A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adults
European Journal of Gastroenterology & Hepatology · 2025
- Gut microbiota strain richness is species specific and affects engraftment
Nature · 2024
- Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study
Journal of Crohn s and Colitis · 2024
- 43 RECOVERY OF MICROBIOME FUNCTIONAL PATHWAYS INVOLVED IN STICKLAND FERMENTATION IN PATIENTS RECEIVING VE303, A DEFINED BACTERIAL CONSORTIUM FOR CLOSTRIDIOIDES DIFFICILE INFECTION (CDI)
Gastroenterology · 2024
- Gastroenterology×8
- Gastrointestinal Endoscopy×3
- Nature×2
- mBio×2
- Open Forum Infectious Diseases×2
- Emily Briggs
Medicine · University of Michigan
- Monika Fischer
Medicine · Indiana University
- Vincent B. Young
Medicine · University of Michigan
- Alexandra K. Standke
Medicine · University of Michigan
- Kimberly C. Vendrov
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile